Ind-Swift Labs.

INDSWIFTLABORATORIES29 Apr 2024

Pharmaceuticals

₹

-3.00 (-2.40%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Ind-Swift Labs.

Ind-Swift Labs.

Pharmaceuticals

INDSWIFTLABORATORIES29 Apr 2024

₹

-3.00 (-2.40%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
25-May-2011	D	Ind-Swift Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2011, inter alia, has taken the following decisions: 1. The Board has recommended a dividend of Rs 1/- per share on Equity Shares of Rs.10/- each the Company.	20-Sep-2011
30-May-2010	D	Ind-Swift Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2010, inter alia, has approved the following: The Board recommended a dividend of Rs. 1/ per share of Rs. 10/- each.	16-Sep-2010
30-Jun-2009	D	Ind Swift Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 29, 2009, inter alia, has taken the following decisions: The Board has recommended a dividend of 10% on the Equity Shares of the Company.	17-Sep-2009
19-Jun-2008	D	Ind Swift Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 19, 2008, inter alia, has taken the following decisions: The Board has recommended a dividend of 10% on the Equity Shares of the Company.	18-Sep-2008
30-Jul-2007	D	Ind Swift Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 30, 2007, inter alia, has recommended a dividend of 10% on the Equity Shares of the Company.	21-Sep-2007
14-Jun-2005	D	15% Dividend	22-Sep-2005
31-Aug-2023	BC	Outcome of Board Meeting held on 31st August, 2023	10-May-2024
03-Apr-2024	BC	EC Special Situations Fund & PACs	01-Apr-2024
30-Mar-2024	BC	please refer attached pdf.	30-Mar-2024
30-Mar-2024	BC	Source: BSE Announcement PDF	29-Mar-2024
30-Mar-2024	BC	ESSIX BIOSCIENCES LIMITED	28-Mar-2024

Announcement Date25-May-2011

Ex Dividend Date20-Sep-2011

Dividend(%)10

Announcement Date30-May-2010

Ex Dividend Date16-Sep-2010

Dividend(%)10

Announcement Date30-Jun-2009

Ex Dividend Date17-Sep-2009

Dividend(%)10

Announcement Date19-Jun-2008

Ex Dividend Date18-Sep-2008

Dividend(%)10

Announcement Date30-Jul-2007

Ex Dividend Date21-Sep-2007

Dividend(%)10

Announcement Date14-Jun-2005

Ex Dividend Date22-Sep-2005

Dividend(%)15

No Rights has been declared by INDSWIFTLABORATORIES

Book Closure

Record Date	Split Date	Purpose
10-May-2024	-	Outcome of Board Meeting held on 31st August, 2023
01-Apr-2024	-	EC Special Situations Fund & PACs
30-Mar-2024	-	please refer attached pdf.
29-Mar-2024	01 Jan'1900	Source: BSE Announcement PDF
28-Mar-2024	-	ESSIX BIOSCIENCES LIMITED

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Ind-Swift Laboratories Ltd ₹121.95(-3.00/-2.40%)	121.95	-3.00	720.56	78.68	28.73	1.34
Lupin Ltd ₹1,637.45(+21.50/1.33%)	1,637.45	+21.50	74,626.80	131.02	36.21	3.87
Ipca Laboratories Ltd ₹1,334.00(-4.50/-0.34%)	1,334.00	-4.50	33,844.14	88.32	61.44	5.45
J B Chemicals & Pharmaceuticals Ltd ₹1,906.65(+41.60/2.23%)	1,906.65	+41.60	29,590.22	83.33	58.44	11.03
Sanofi India Ltd ₹8,277.50(+3.35/0.04%)	8,277.50	+3.35	19,063.08	52.52	32.30	18.78
IOL Chemicals & Pharmaceuticals Ltd ₹396.50(-3.00/-0.75%)	396.50	-3.00	2,327.67	-3.19	13.49	1.46

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	276.28	270.30	299.01	290.48	302.41	287.55
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	276.28	270.30	299.01	290.48	302.41	287.55
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	7.11	7.40	5.55	9.99	8.36	7.54
Total Income	283.40	277.70	304.56	300.47	310.76	295.09
Total Expenditure	222.04	206.90	239.19	260.79	246.49	230.69
PBIDT	61.36	70.80	65.37	39.68	64.27	64.40
Interest	21.05	21.14	20.38	21.82	22.38	23.98
PBDT	40.30	49.66	44.98	17.86	41.89	40.41
Depreciation	13.56	13.19	13.89	9.29	15.42	16.39
Tax	5.09	6.38	14.05	16.12	-2.76	0.00
Deferred Tax	0.00	0.00	0.00	23.36	0.00	0.00
Reported Profit After Tax	21.65	30.10	17.05	-30.91	29.22	24.02
Extra-ordinary Items	0.00	0.00	0.00	12.84	0.00	0.00
Adjusted Profit After Extra-ordinary item	21.65	30.10	17.05	-43.75	29.22	24.02

EPS (Unit Curr.)	3.66	5.09	2.89	-5.23	4.95	4.07
EPS (Adj) (Unit Curr.)	3.66	5.09	2.89	-5.23	4.95	4.07
Calculated EPS (Unit Curr.)	3.66	5.09	2.89	-5.23	4.95	4.07
Calculated EPS (Adj) (Unit Curr.)	3.66	5.09	2.89	-5.23	4.95	4.07
Calculated EPS (Ann.) (Unit Curr.)	14.66	20.37	11.54	-20.93	19.78	16.26
Calculated EPS (Adj) (Ann.) (Unit Curr.)	14.66	20.37	11.54	-20.93	19.78	16.26
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	59.09	59.09	59.09	59.09	59.09	59.09
Reserve & Surplus	0.00	0.00	449.18	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	22.21	26.19	21.86	13.66	21.25	22.40
PBDTM(%)	14.59	18.37	15.04	6.15	13.85	14.05
PATM(%)	7.84	11.14	5.70	-10.64	9.66	8.35

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	287.51	289.71	310.34	304.25	312.69	310.21
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	287.51	289.71	310.34	304.25	312.69	310.21
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	7.11	7.40	5.61	10.21	8.36	7.54
Total Income	294.63	297.11	315.94	314.45	321.04	317.76
Total Expenditure	235.82	224.02	250.04	267.22	258.92	251.46
PBIDT	58.80	73.09	65.91	47.23	62.12	66.30
Interest	21.05	21.14	20.38	21.82	22.38	23.98
PBDT	37.75	51.95	45.52	25.41	39.74	42.32
Depreciation	13.56	13.19	13.89	9.29	15.39	16.41
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	4.67	6.93	14.24	17.81	-3.27	0.56
Deferred Tax	0.00	0.00	0.00	23.36	0.00	0.00
Reported Profit After Tax	19.53	31.83	17.40	-25.05	27.62	25.34
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	19.42	31.66	17.24	-25.12	27.50	25.34

Extra-ordinary Items	0.00	0.00	0.00	14.52	0.00	0.00
Adjusted Profit After Extra-ordinary item	19.42	31.66	17.24	-39.64	27.50	25.34

EPS (Unit Curr.)	3.29	5.36	2.92	-4.25	4.65	4.29
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	59.09	59.09	59.09	59.09	59.09	59.09

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	20.45	25.23	21.24	15.52	19.87	21.37
PBDTM(%)	13.13	17.93	14.67	8.35	12.71	13.64
PATM(%)	6.79	10.99	5.61	-8.23	8.83	8.17

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	59.81	59.81	59.81	59.81	48.29	46.00
Reserves Total	615.54	572.75	578.89	584.80	542.00	497.38
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	675.35	632.56	638.70	644.61	590.29	543.38
Secured Loans	839.41	929.23	963.51	973.35	1075.23	1034.21
Unsecured Loans	14.34	14.88	32.94	57.97	73.00	48.86
Total Debt	853.75	944.11	996.45	1031.32	1148.23	1083.07
Total Liabilities	1529.10	1576.67	1635.15	1675.93	1738.52	1626.45
APPLICATION OF FUNDS :
Gross Block	1333.47	1318.52	1316.03	1355.93	1393.32	1360.58
Less : Accumulated Depreciation	746.04	689.03	563.62	513.00	479.86	426.56
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	587.43	629.49	752.41	842.93	913.46	934.02
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	7.71	10.31	18.84	11.45	19.87	68.60
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	85.12	110.68	55.33	26.36	26.41	26.42
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	427.54	414.00	354.41	342.82	316.61	316.91
Sundry Debtors	469.49	428.35	400.15	384.66	333.47	382.82
Cash and Bank	9.96	9.38	9.95	8.84	29.09	6.43
Loans and Advances	167.08	146.44	101.30	108.24	138.13	102.34
Total Current Assets	1074.07	998.16	865.81	844.57	817.30	808.51
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	229.39	204.12	165.46	169.31	159.69	357.27
Provisions	11.87	4.96	0.69	0.00	0.00	0.00
Total Current Liabilities	241.26	209.08	166.16	169.31	159.69	357.27
Net Current Assets	832.81	789.08	699.65	675.25	657.61	451.24
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	29.85	50.38	58.84	165.12	182.38	210.83
Deferred Tax Liability	0.00	0.00	0.00	87.15	103.56	114.82
Net Deferred Tax	29.85	50.38	58.84	77.97	78.82	96.01
Total Assets	1542.91	1589.95	1585.07	1633.96	1696.17	1576.29
Contingent Liabilities	7.97	35.68	40.09	22.83	52.39	98.91

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	59.81	59.81	59.81	59.81	48.29	46.00
Reserves Total	622.12	541.17	543.70	580.83	539.53	507.24
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	681.93	600.98	603.51	640.64	587.82	553.24
Minority Interest	0.00	-0.11	-0.09	0.00	0.00	0.00
Secured Loans	796.30	906.00	944.93	973.33	1075.21	1034.21
Unsecured Loans	65.77	46.99	60.39	57.97	73.00	48.86
Total Debt	862.07	952.99	1005.32	1031.30	1148.21	1083.07
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	17.91	17.18	15.90	14.96	14.57	13.32
Total Liabilities	1561.91	1571.04	1624.64	1686.90	1750.60	1649.63
APPLICATION OF FUNDS :
Gross Block	1334.24	1322.26	1319.98	1357.46	1393.53	1360.79
Less: Accumulated Depreciation	746.77	692.03	566.56	514.32	479.86	426.56
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	587.47	630.23	753.42	843.14	913.67	934.23
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	7.71	10.31	18.84	11.45	19.87	68.60
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	30.34	29.06	35.53	17.45	18.56	18.32
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	438.60	428.50	375.67	342.82	316.61	316.91
Sundry Debtors	505.32	454.78	432.39	396.45	350.85	407.76
Cash and Bank	18.20	21.48	11.60	10.58	29.97	9.45
Loans and Advances	202.39	170.57	124.52	113.19	138.66	108.21
Total Current Assets	1164.51	1075.33	944.18	863.03	836.09	842.33
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	249.90	224.38	192.82	183.12	173.06	370.76
Provisions	12.25	5.39	0.98	0.00	0.31	2.60
Total Current Liabilities	262.15	229.77	193.80	183.12	173.37	373.36
Net Current Assets	902.37	845.56	750.37	679.92	662.72	468.97
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	29.87	51.90	60.36	165.12	182.38	210.83
Deferred Tax Liability	0.00	0.00	0.00	87.15	103.56	114.82
Net Deferred Tax	29.87	51.90	60.36	77.97	78.82	96.01
Other Assets	4.17	3.96	6.11	56.95	56.95	63.50
Total Assets
Contingent Liabilities	7.97	35.68	40.09	22.83	52.39	98.91

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	9.38	9.95	8.84	29.09	6.43
Net Cash from Operating Activities	182.67	136.26	135.03	123.16	-74.63
Net Cash Used In Investing Activities	-13.69	2.76	-10.17	-10.15	-2.34
Net Cash Used In Financing Activities	-168.41	-139.59	-123.75	-133.26	99.62
Net Inc./Dec In Cash And Cash Equivalents	0.58	-0.57	1.11	-20.25	22.66
Cash And Cash Equivalents At End Of The Year	9.96	9.38	9.95	8.84	29.09

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

42.00%

FII Shareholding

0.25%

DII Shareholding

8.03%

Public Shareholding

49.72%

**Promoter pledged shareholding 42.00%

About Ind-Swift Laboratories Ltd

Ind-Swift Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 719.8 crores. It has reported a sales of Rs. 276.28 crores and a net profit of Rs. 21.65 crores for the quarter ended December 2018. The company management includes N R Munjal, N R Munjal,Himanshu Jain,Pradeep Verma,Rishav Mehta,S P Sharma,Neerja Chathley,Ashwani K Vig,Sahil Munjal,Rajendra Kumar Gupta (Ind-Swift Laboratories Ltd) among others.

Chairman

N R Munjal

Registered office

SCO 850 Shivalik Enclave,NAC Manimajra,Chandigarh,Chandigarh,160101

FAX :91-0172-2730504/2736294

Background

Incorporation Year1995

Face Value₹10

Market Lot1

How to buy Ind-Swift Labs. shares on nse?

To buy Ind-Swift Labs. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Ind-Swift Labs. share price today?

The Ind-Swift Labs. shares price on nse is Rs.121.95 today.

What is the market cap of Ind-Swift Labs. shares on NSE ?

The company has a market capitalization of Rs.720.56Cr

What is the PE & PB ratio of Ind-Swift Labs. shares ?

PE is 28.73 and PB is 1.34

What is the 52 Week High and Low of Ind-Swift Labs. shares?

Ind-Swift Labs. stock price high: Rs.138.45 Ind-Swift Labs. stock price low: Rs.63.95